Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for BioSig Technologies Inc. (BSGM:NASDAQ), powered by AI.
BioSig Technologies Inc. is currently trading at $0.99. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for BioSig Technologies Inc. on Alpha Lenz.
BioSig Technologies Inc.'s P/E ratio is -1.3.
“BioSig Technologies Inc. trades at a P/E of -1.3 (undervalued) with strong ROE of 474.7%.”
Ask for details →BioSig Technologies Inc. is a medical technology company that specializes in developing advanced biomedical signal processing solutions. Its primary function is to enhance the performance and accuracy of cardiac electrophysiology data analysis, ultimately improving the diagnostic capabilities of healthcare providers. The company's notable creation, the PURE EP System, is designed to provide significant advancements in electrophysiology procedures by delivering clearer and more precise signals to clinicians treating arrhythmias. BioSig Technologies operates within the healthcare technology sector, impacting hospitals, research institutions, and clinics that prioritize innovative solutions for cardiac care. Based in the United States and founded in 2009, BioSig Technologies plays a significant role in the medical field by striving to transform how cardiac arrhythmias are understood and treated, thus contributing to the evolution of patient care and procedural efficiency.
“BioSig Technologies Inc. trades at a P/E of -1.3 (undervalued) with strong ROE of 474.7%.”
Ask for details →BioSig Technologies Inc. (ticker: BSGM) is a company listed on NASDAQ in the Healthcare sector (Medical Devices). It has approximately 5 employees. Market cap is $14M.
The current price is $0.985 with a P/E ratio of -1.34x and P/B of -9.62x.
ROE is 474.72% and operating margin is -31522.50%. Annual revenue is $40,000.